He invented two new drugs to treat melanoma

After more than three decades of not finding new drugs to treat melanoma, British laboratories have devised two new drugs to treat this tumor: Dabrafenib and Trametinib.

Melanoma

According to British scientists, Trametinib can neutralize a protein called MEK that stimulates the growth of melanoma while Dabrafenib can prevent a mutant gene called BRAF to produce a Protein promotes the growth of this tumor.

According to the scientists, in people treated with trametinib, melanoma did not develop in 4.8 months, ie a 55% reduction in development risk compared to 1 and a half months in those receiving the treatment chemotherapy.

Meanwhile, Dabrafenib treatment also showed a 70% reduction in the risk of melanoma in 5.1 months compared to those treated with classical chemotherapy.